Af­ter an in­fant last year was saved from a dead­ly dis­easethanks to a be­spoke gene edit­ing ther­a­py that fixed an in­cred­i­bly rare mu­ta­tion in...

Af­ter more than a decade of work and plen­ty of ups and downs, Roche has dropped its Hunt­ing­ton’s dis­ease drug tomin­ersen.

The de­ci­sion comes af­ter...

A new­ly pro­posed HHS rule would es­tab­lish a com­pen­sa­tion mech­a­nism for peo­ple who claim they were in­jured by Covid-19 vac­cines, as a key pan­el that...

The FDA has paused its pub­lic re­lease of phar­ma re­jec­tion let­ters as the agency seeks to avoid lit­i­ga­tion around re­leas­ing the of­ten sen­si­tive in­for­ma­tion.

The...

The UK’s drug pric­ing watch­dog said gov­ern­ment re­im­burse­ment of Am­gen’s lung can­cer drug Lumakras should be cut off for new pa­tients.

In draft guid­ance re­leased...